Company intelligence / Profile preview

Compumedics

Abbotsford, Victoria, Australiacompumedics.com.au ↗

Ownership: Public · CMP
Employees: ~150
Development stage: Other

Overview

Compumedics has a long-standing track record in commercializing medical diagnostic devices for sleep medicine, neurology/neurophysiology research, and ultrasonic blood-flow monitoring. Its products are widely used in clinical settings globally. The company has received regulatory clearances including FDA approval since the late '90s. No drug or therapeutic clinical trial results apply as it focuses on non-invasive diagnostics.

Therapeutic areas: NeurologyCardiovascular
Modalities: DeviceNon-pharmacological therapy
Industry: Physiological Monitoring

Partnerships

Bestmed China distributor partnershipKorea Research Institute of Standards and Science licensing agreement for MEG technology transfer

Financials

Market cap: $1.1B
Total revenue: $215.3M
Enterprise value: $1.7B

Beyond the preview

Go deeper on Compumedics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Compumedics.

Explore the full profile